home / stock / akblf / akblf short
Short Information | Alk-Abello A/S (OTCMKTS:AKBLF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 14,141 |
Total Actual Volume | 21,441 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 19 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 707 |
Average Short Percentage | 92.67% |
Is there a AKBLF Short Squeeze or Breakout about to happen?
See the AKBLF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-19-2024 | $17.9 | $17.9 | $17.9 | $17.9 | 19 | 19 | 100% |
03-27-2024 | $18.4 | $18.4 | $18.4 | $18.4 | 633 | 633 | 100% |
02-20-2024 | $19.9 | $18.5 | $19.9 | $18.5 | 3,000 | 1,500 | 50% |
02-08-2024 | $17.31 | $17.31 | $17.31 | $17.31 | 40 | 40 | 100% |
01-12-2024 | $0 | $13.25 | $0 | $0 | 575 | 575 | 100% |
01-11-2024 | $0 | $13.25 | $0 | $0 | 4,196 | 4,196 | 100% |
10-23-2023 | $11 | $11 | $11 | $11 | 100 | 100 | 100% |
08-28-2023 | $12.3 | $12.3 | $12.3 | $12.3 | 452 | 452 | 100% |
08-21-2023 | $11.05 | $11.05 | $11.05 | $11.05 | 10 | 10 | 100% |
08-11-2023 | $11.35 | $11.35 | $11.35 | $11.35 | 700 | 700 | 100% |
07-07-2023 | $11.2 | $8.7 | $11.2 | $8.2 | 6,002 | 202 | 3.37% |
06-01-2023 | $0 | $12.06 | $0 | $0 | 1 | 1 | 100% |
04-12-2023 | $14 | $14 | $14 | $14 | 250 | 250 | 100% |
11-11-2022 | $14.9 | $14.9 | $14.9 | $14.9 | 10 | 10 | 100% |
11-04-2022 | $0 | $16.23 | $0 | $0 | 5,000 | 5,000 | 100% |
09-14-2022 | $19.85 | $19.85 | $19.85 | $19.85 | 250 | 250 | 100% |
08-24-2022 | $19.235 | $19.235 | $19.235 | $19.235 | 100 | 100 | 100% |
05-17-2022 | $18.95 | $18.95 | $18.95 | $18.95 | 100 | 100 | 100% |
01-21-2022 | $431.5 | $431.5 | $431.5 | $431.5 | 2 | 2 | 100% |
11-08-2021 | $469 | $469 | $469 | $469 | 1 | 1 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Alk-Abello A/S Company Name:
AKBLF Stock Symbol:
OTCMKTS Market:
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 14 March 2024 at 4:00 PM (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The agenda of the meeting including the complete proposals from the B...
08 February 2024 ALK’s ( ALKB:DC / OMX: ALK B / AKBLF ) Board of Directors has approved the company’s 2023 annual report. Following a robust performance in Q4, full-year results were in line with the latest outlook. ALK expects to continue its growth trajectory and earning...
The trial now progresses into its second part, expected to complete later in 2024. ALK to submit a protocol amendment for Phase 1-2 efficacy trial extension. ALK ( ALKB:DC / OMX: ALK B / AKBLF ) announced today that it has completed the first part of its phase 1 clinical trial...